BAXTER INTERNATIONAL: To Appeal US$500 Million Profopol Ruling
Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the company and Teva Pharmaceuticals USA, Inc. (Teva) intends to appeal a US$500 million adverse decision in Nevada.
The company…